This application for renewal proposes to continue our investigation of novel mechanisms involved in insulin regulation of hepatic glucose fluxes. Our long-term goal has been to improve our understanding of the link between nutrient availability and liver glucose output. During the last funding period we demonstrated that bi-directional changes in hypothalamic insulin signaling can regulate liver glucose homeostasis in mice and rats. Here we wish to investigate the biochemical signaling steps required for these effects and how they are modified in insulin resistant models. Specifically, we wish to examine the following questions: 1. Does insulin regulate hepatic glucose fluxes via activation of PI(3)K/Akt-dependent pathways within the mediobasal hypothalamus? 2. Does insulin regulate hepatic glucose fluxes via activation of FOXO1- and/or nNOS- dependent pathways within the mediobasal hypothalamus? 3. Does insulin inhibit hepatic glucose production when the activation of hypothalamic malonyl-CoA-dependent pathways is prevented? 4. Is the activation of hypothalamic insulin signaling sufficient to rescue hepatic insulin action in genetic mouse models of hypothalamic insulin resistance? 5. Is the activation of hypothalamic insulin signaling sufficient to rescue hepatic insulin action in a rat model of diet-induced hepatic insulin resistance? The experiments proposed in this application should allow us to clarify the early biochemical events necessary for hypothalamic insulin signaling and how they are modified in animal models of hepatic insulin resistance.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK045024-19
Application #
7800857
Study Section
Integrative Physiology of Obesity and Diabetes Study Section (IPOD)
Program Officer
Laughlin, Maren R
Project Start
1991-08-01
Project End
2012-03-31
Budget Start
2010-04-01
Budget End
2012-03-31
Support Year
19
Fiscal Year
2010
Total Cost
$435,635
Indirect Cost
Name
Albert Einstein College of Medicine
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
110521739
City
Bronx
State
NY
Country
United States
Zip Code
10461
Arrieta-Cruz, Isabel; Su, Ya; Gutiérrez-Juárez, Roger (2016) Suppression of Endogenous Glucose Production by Isoleucine and Valine and Impact of Diet Composition. Nutrients 8:79
Arrieta-Cruz, Isabel; Knight, Colette M; Gutiérrez-Juárez, Roger (2015) Acute Exposure of the Mediobasal Hypothalamus to Amyloid-?25-35 Perturbs Hepatic Glucose Metabolism. J Alzheimers Dis 46:843-8
Pereira, Sandra; Park, Edward; Mori, Yusaku et al. (2014) FFA-induced hepatic insulin resistance in vivo is mediated by PKC?, NADPH oxidase, and oxidative stress. Am J Physiol Endocrinol Metab 307:E34-46
Haeusler, Rebecca A; Hartil, Kirsten; Vaitheesvaran, Bhavapriya et al. (2014) Integrated control of hepatic lipogenesis versus glucose production requires FoxO transcription factors. Nat Commun 5:5190
Arrieta-Cruz, Isabel; Su, Ya; Knight, Colette M et al. (2013) Evidence for a role of proline and hypothalamic astrocytes in the regulation of glucose metabolism in rats. Diabetes 62:1152-8
Ren, Hongxia; Orozco, Ian J; Su, Ya et al. (2012) FoxO1 target Gpr17 activates AgRP neurons to regulate food intake. Cell 149:1314-26
Su, Ya; Lam, Tony K T; He, Wu et al. (2012) Hypothalamic leucine metabolism regulates liver glucose production. Diabetes 61:85-93
Kishore, P; Kehlenbrink, S; Hu, M et al. (2012) Xylitol prevents NEFA-induced insulin resistance in rats. Diabetologia 55:1808-12
Kishore, Preeti; Boucai, Laura; Zhang, Kehao et al. (2011) Activation of K(ATP) channels suppresses glucose production in humans. J Clin Invest 121:4916-20
Shishova, Ekaterina Y; Stoll, Janis M; Ersoy, Baran A et al. (2011) Genetic ablation or chemical inhibition of phosphatidylcholine transfer protein attenuates diet-induced hepatic glucose production. Hepatology 54:664-74

Showing the most recent 10 out of 31 publications